Alaska has become the 11th state to restrict the sale of products containing dextromethorphan (DXM) to residents aged 18 years and older, or younger than aged 18 years with a prescription from a licensed practitioner. "Thank you to my colleagues for passing this bill to protect Alaska teens, the largest risk group for these powerful medicines," said Rep. Charisse Millett (R-Anchorage), the House Majority Leader, when the bill passed through the Alaska House earlier this year. "When used correctly, medicines with DXM are safe; high doses can lead to some nasty outcomes, like hallucinations, blurred visions, and loss of motor control. We need to keep our kids safe. That's how HB125 can help." Millett cited a 2013 study by the National Institute on Drug Abuse that found 4% of 8th–12th graders had intentionally consumed excessive amounts of cough medicine.